Michael Gelband ExodusPoint Capital Management
Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$353M |
| 2 |
Microsoft
MSFT
|
+$352M |
| 3 |
Apple
AAPL
|
+$256M |
| 4 |
Alibaba
BABA
|
+$189M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$125M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SCHW
Charles Schwab
SCHW
|
+$82M |
| 2 |
Generac Holdings
GNRC
|
+$33.7M |
| 3 |
Pool Corp
POOL
|
+$32.5M |
| 4 |
Keurig Dr Pepper
KDP
|
+$31M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$25M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.28% |
| 2 | Consumer Discretionary | 10.77% |
| 3 | Healthcare | 5.09% |
| 4 | Industrials | 4.03% |
| 5 | Financials | 3.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1551
Turning Point Brands
TPB
$1.67B
| $295K | ﹤0.01% |
+6,619
| New | +$250K |
|
1552
AudioEye
AEYE
$91.9M
| $294K | ﹤0.01% |
+11,365
| New | +$215K |
|
1553
Perdoceo Education
PRDO
$2.07B
| $294K | ﹤0.01% |
+23,271
| New | +$280K |
|
1554
Agilysys
AGYS
$3.21B
| $293K | ﹤0.01% |
+7,638
| New | +$254K |
|
1555
Editas Medicine
EDIT
$461M
| $293K | ﹤0.01% |
4,176
-42,843
| -91% | -$1.76M |
|
1556
Marriott International
MAR
$93.9B
| $291K | ﹤0.01% |
+2,204
| New | +$252K |
|
1557
Wave Life Sciences
WVE
$1.01B
| $290K | ﹤0.01% |
36,793
-64,994
| -64% | -$546K |
|
|
STON
1558
DELISTED
StoneMor Inc.
STON
| $290K | ﹤0.01% |
+110,358
| New | +$145K |
|
1559
Forestar Group
FOR
$1.47B
| $289K | ﹤0.01% |
+14,300
| New | +$272K |
|
1560
Powell Industries
POWL
$6.89B
| $289K | ﹤0.01% |
29,355
-7,926
| -21% | -$70.6K |
|
|
HAYN
1561
DELISTED
Haynes International, Inc.
HAYN
| $289K | ﹤0.01% |
12,125
-7,139
| -37% | -$148K |
|
1562
Saic
SAIC
$5.36B
| $288K | ﹤0.01% |
+3,039
| New | +$267K |
|
|
GOCO
1563
DELISTED
GoHealth
GOCO
| $287K | ﹤0.01% |
1,401
-632
| -31% | -$117K |
|
1564
UFP Industries
UFPI
$4.92B
| $287K | ﹤0.01% |
5,159
-786
| -13% | -$43.1K |
|
1565
CareTrust REIT
CTRE
$9.37B
| $286K | ﹤0.01% |
12,878
-10,020
| -44% | -$197K |
|
1566
Neogen
NEOG
$2.53B
| $286K | ﹤0.01% |
7,222
-372
| -5% | -$13.8K |
|
|
SVC
1567
Service Properties Trust
SVC
$1.04B
| $286K | ﹤0.01% |
4,984
-1,321
| -21% | -$67.1K |
|
1568
Gentex
GNTX
$4.97B
| $285K | ﹤0.01% |
8,410
-53,694
| -86% | -$1.66M |
|
1569
nCino
NCNO
$2.3B
| $285K | ﹤0.01% |
3,936
-32,590
| -89% | -$2.52M |
|
|
LDL
1570
DELISTED
Lydall, Inc.
LDL
| $285K | ﹤0.01% |
+9,493
| New | +$229K |
|
|
BPYU
1571
DELISTED
Brookfield Property REIT Inc. Class A Common Stock
BPYU
| $285K | ﹤0.01% |
19,067
-17,122
| -47% | -$260K |
|
1572
OraSure Technologies
OSUR
$263M
| $283K | ﹤0.01% |
+26,713
| New | +$350K |
|
1573
StepStone Group
STEP
$4.05B
| $283K | ﹤0.01% |
7,121
-42,559
| -86% | -$1.23M |
|
|
FRTA
1574
DELISTED
Forterra, Inc
FRTA
| $282K | ﹤0.01% |
16,397
-54,610
| -77% | -$874K |
|
1575
Fastenal
FAST
$58.8B
| $281K | ﹤0.01% |
+11,524
| New | +$271K |
|
Similar funds
Michael Gelband's Q4 2020 Portfolio in Review
As of Q4 2020, Michael Gelband held 2,600 positions worth $10.3B, up 105% from $5.02B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Michael Gelband deployed $4.62B of net new capital in Q4 2020, opening 918 new positions and adding to 493 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 352,707 shares worth $132M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 11% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Charles Schwab, an estimated $82M trimmed.
- Michael Gelband's largest Q4 2020 buy was State Street SPDR S&P 500 ETF Trust: 352,707 shares worth $132M.
- Michael Gelband added most to Amazon in Q4 2020, an estimated $353M increase.
- Michael Gelband's biggest Q4 2020 reduction was Charles Schwab, cutting an estimated $82M.
- Michael Gelband fully exited Eli Lilly in Q4 2020, selling an estimated $21.7M.
- Michael Gelband's ten largest holdings make up 42% of its $10.3B portfolio in Q4 2020.
- Michael Gelband opened 918 new positions and closed 701 in Q4 2020.
- Michael Gelband's portfolio value rose 105% quarter-over-quarter to $10.3B.
Based on ExodusPoint Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.